Wooldridge James 4
4 · Aeglea BioTherapeutics, Inc. · Filed Aug 24, 2017
Insider Transaction Report
Form 4
Wooldridge James
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2017-08-22+165,000→ 165,000 totalExercise: $3.10Exp: 2027-08-21→ Common Stock (165,000 underlying) - Award
Employee Stock Option (right to buy)
2017-08-22+10,000→ 10,000 totalExercise: $3.10Exp: 2027-08-21→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The stock option vests and becomes exercisable as to 1/4th of the shares subject to the option on July 10, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
- [F2]The stock option vests and becomes exercisable as to 50% of the shares subject to the option on August 22, 2018, an additional 30% of the shares subject to the option on August 22, 2019, and the remaining 20% of the shares subject to the option on August 22, 2020, subject to the continuing employment of the Reporting Person on each vesting date.